Background Epidemiology data regarding hidradenitis suppurativa (HS) are conflicting and
prevalence estimates vary 80‐fold, from 0·05% in a population‐based study to 4%. …

Background A needs assessment for patients with hidradenitis suppurativa (HS) will support
advancements in multidisciplinary care, treatment, research, advocacy, and philanthropy. …

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease defined clinically by
multiple, painful inflammatory lesions occurring predominantly in flexural sites. Onset is …

Objective This study aimed to measure the impact of COVID-19 on the quality of life (QoL) of
survivors and their partners and family members. Design and setting A prospective cross-…

The 14 authors of the first review article on hidradenitis suppurativa (HS) pathogenesis
published 2008 in EXPERIMENTAL DERMATOLOGY cumulating from the 1st International …

Background There is no consensus on core outcome domains for hidradenitis suppurativa (HS).
Heterogeneous outcome measure instruments in clinical trials likely leads to outcome‐…

Smoking tobacco is associated with a number of gastrointestinal disorders. In some, such
as Crohn's disease and peptic ulcer disease, it increases the risk of disease and has a …

In discussing the etiology of HS, potential causes can be subdivided into genetic, microbiological,
endocrine, and environmental factors such as obesity and smoking. The question,“To …

Immediately after electrical stimulation, the paired m. longissimus thoracis et lumborum (LT)
of 40 sheep were boned out and wrapped tightly with a polyethylene cling film. One of the …

More than 50 interventions have been used to treat hidradenitis suppurativa (HS), and so
therapy decisions can be challenging. Our objective was to summarize and appraise …